If you have a conflict of interest related to an assigned manuscript, we ask that you decline to review the manuscript; we will reassign it. A conflict of interest may include (a) personal conflict [a good or bad relationship with the author or institution], (b) financial conflict [e.g., stock in a drug company or competing technology], (c) intellectual conflict [a strong interest in seeing the research published or not published], or (d) other conflict that you identify.

All material in the manuscript is confidential. Please do not share the manuscript or its contents with anyone else.

Organization and Content
There are three parts of your review: (a) reviewer recommendation, (b) confidential comments to editor, and (c) comments to author.

Based on overall assessment of manuscript quality and importance of the topic, reviewers submit their recommendation for the manuscript to be considered by the editor. Options are to accept, accept with major revision, accept with minor revision, or reject. The recommendations of each reviewer are confidential and accessed only by the editor; the author and other reviewers do not have access to these recommendations and they are not communicated to them.

Please provide comments to the editor if you have confidential comments that you want only the editor to look at such as concerns about misconduct regarding the manuscript or duplicate publication or overlapping publication; or any other concern that you may have and want to submit confidentially.

Please do not include your recommendation about publication in the Comments to the Author; and do not indicate any information that reveals your identity as well. Comments to the author should address comments on major sections of the manuscript: Problem Statement, Background and Literature, Research design and method, Data analysis, Results, Discussion, Organization and style of presentation.